Needham raises PT to $73 From $70, Keeps Buy Rating | ITCI Message Board Posts


Intra-Cellular Therapies, Inc.

  ITCI website

ITCI   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  447 of 461  at  7/7/2023 12:22:25 AM  by

redhotace

The following message was updated on 7/7/2023 12:24:57 AM.

Needham raises PT to $73 From $70, Keeps Buy Rating

Needham raises PT to $73 From $70, Keeps Buy Rating
 

08:33 AM EDT, 07/06/2023 (MT Newswires) -- Intra-Cellular Therapies (ITCI) has an average rating of outperform and price targets ranging from $58 to $98, according to analysts polled by Capital IQ.

 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...